Mr. Nicholas Stroumbakis, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 |
Courtney Adair Chenault, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 |
Mr. Mark Taafel, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7403 Fax: 203-732-7177 |
Nicole Marie Wolf, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 |
Megan E Cecchi, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 |
News Archive
Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.
IVAX Corporation announced today a revised offer to acquire the shares of Kutnowskie Zaklady Farmaceutyczne Polfa SA ("Polfa Kutno"). IVAX intends to acquire, in exchange for IVAX stock, up to 100%, but not less than 75% of the shares of Polfa Kutno for a price of 340 PLN per share.
Comments made last week by Archbishop Francisco Chimoio, head of the Roman Catholic Church in Mozambique, that two European countries make condoms deliberately tainted with HIV as part of a plan "to finish quickly the African people" are "lunatic theories" and "baseless allegations," a Los Angeles Times editorial says (Los Angeles Times, 9/29).
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
› Verified 7 days ago